# Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers

> **NCT05662865** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **AdventHealth Translational Research Institute** · enrollment: 9 (actual)

## Conditions studied

- Ketones, Metabolism

## Interventions

- **DRUG:** SGLT2 inhibitor
- **OTHER:** Controlled, Adaptive Study Diet

## Key facts

- **NCT ID:** NCT05662865
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-16
- **Primary completion:** 2024-07-23
- **Final completion:** 2026-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05662865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05662865, "Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05662865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*